Seasons Greetings from the Team at The Sentiment!
We’ll now be taking some time off to enjoy with our families but below are a few of the most popular stories of 2023 and look forward to returning in the New Year.
ASX News
Scarless healing one step closer as Fiona Wood-led clinical trials demonstrate collagen reduction
Payroll tax controversy hits Pacific Smiles in New South Wales
Invest in good investors, UNITH delivers big jump in value behind tech of its digital humans
PharmAust completes dosing first cohort for MND treatment, patients respond positively
As allied health services thrive, Healthia receive $260m offer to be acquired at 84% premium
Aussie cancer researcher primed for 2023 with groundbreaking clinical trial data releases scheduled
FBR strikes $9 million deal to manufacture Hadrian X robots for the USA
IOUPay undertakes major board change, loses share value as company undergoes turmoil
Explainers
Do you really own your shares?
Investing basics: The risks of investing in mining companies
Investing basics: CHESS accounts vs Custodial accounts
To all of our loyal readers and social media followers, we thank you for your ongoing readership and are delighted to make your investing experience better.
Regards,
Conor Murphy
Editor
Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…
Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…
Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…
Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…
The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…
Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…